We've seen a similar post before.
The patent examiner says that some of Daniel Tillett's claims in his MRD application lack novelty because Rothman (the former RAC CMO) and the Nagler 1 trial at Sheba allegedly were first.
Not that any parties unknown to RAC were first.
Amyway, this doesn't affect any trials other than a future MRD trial.
General Comments / Chat, page-4112
-
- There are more pages in this discussion • 7,203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.73 |
Change
0.170(10.9%) |
Mkt cap ! $294.7M | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.73 | $1.57 | $550.9K | 332.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | $1.71 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.73 | 999 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |